T cells and T cell tumors efficiently generate antigen-specific cytotoxic T cell immunity when modified with an NKT ligand.

"Disclosure of Potential Conflicts Of Interest Statement No potential conflicts of interests were disclosed."

"We thank Dr. Hao Shen for Listeria-Ova, the FACS Core Facility at the MD Anderson for assistance with cell sorting and the NIH tetramer core facility (Atlanta, GA) for providing PBS57-loaded CD1d-tetramers. This study was funded in part by grants from the National Institutes of Health (C.D.) and an MD Anderson Interdisciplinary Research Project (C.D.). C.D. is a Cancer Research Institute Investigator and a Research Trust Fellow of MD Anderson Cancer Center. D.Z. is supported by MD Anderson Cancer Center and a Developmental Award from NCI Joe Moakley Leukemia Spore grant. The Flow Cytometry Core Facility is supported by The University of Texas MD Anderson Cancer Center Support Grant CA16672 (NIH)."